Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in WomenJared M. Baeten, Zeda Rosenberg, Thesla Palanee‐Phillips et al.|New England Journal of Medicine|2016Cited by 768
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in WomenJared M. Baeten, Zeda Rosenberg, Thesla Palanee‐Phillips et al.|Obstetrical & Gynecological Survey|2016Cited by 373
Favoring “Peace of Mind”: A Qualitative Study of African Women's HIV Prevention Product Formulation Preferences from the MTN-020/ASPIRE TrialAriane van der Straten, Felix Mhlanga, Mary Kate Shapley‐Quinn et al.|AIDS Patient Care and STDs|2017Cited by 46
Elevated Risk of Bacterial Vaginosis Among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort StudyKathryn Peebles, Felix Mhlanga, Flavia Matovu Kiweewa et al.|Clinical Infectious Diseases|2020Cited by 44
Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women Using the Dapivirine Vaginal RingRandy M. Stalter, Felix Mhlanga, Lydia Soto‐Torres et al.|The Journal of Infectious Diseases|2023Cited by 2